Case Studies

This case study illustrates the use of one-on-one interviews with Medical Directors from U.S. private insurance carriers. The interviews were conducted in order to assist a major U.S. based university with de-risking its corporate licensing efforts.

This case study demonstrates two points. First in the absence of traditional reimbursement other monetization pathways maybe available. The other point is to show how reimbursement can be used to define their Indications for Use (IFU), and the claims and labeling language prior to formal discussions with the FDA.

This case study demonstrates the importance of reimbursement planning commencing in the R&D phase. This study is intended to demonstrate why payers’ coverage policy decisions, not coding, is a major reason for payers to deny reimbursement of new medical technologies.

This case study shows how we identified multiple monetization pathways for a smartphone and tablet-based test. This study is also intended to demonstrate the company’s reimbursement planning should had begun three years, not one year, prior to product launch.

This case study illustrates the use of payer, hospital utilization and other reimbursement data to assist with investment decision making.

This case study illustrates the use of payer and reimbursement data for decisions related to a company’s sales and marketing operations, specifically the location of its U.S based sales representatives.